Medicine guide

BRIDION

As listed in the register: BRIDION 100 MG/ML SOLUCION INYECTABLE

100 mg · solución inyectable

  • Prescription only
  • Everything that fits nowhere else, such as contrast media
Active substance
Sugammadex
Made by
Merck Sharp & Dohme B.V.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Medicine groupEverything that fits nowhere else, such as contrast mediaV03AB35

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

How it works

From the US prescribing label for the same active substance (sugammadex). It describes the substance, not this exact product.

Sugammadex Injection is a modified gamma cyclodextrin.

It forms a complex with the neuromuscular blocking agents rocuronium and vecuronium, and it reduces the amount of neuromuscular blocking agent available to bind to nicotinic cholinergic receptors in the neuromuscular junction.

Half-life172–8 days
Mostly cleared after≈ 64 weeksfive half-lives — our arithmetic
How it leaves the body

Ninety-six percent (96%) of the dose was excreted in urine, of which at least 95% could be attributed to unchanged sugammadex.

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-09-09

Safety of the active substance

From the US prescribing label for the same active substance (sugammadex). It describes the substance, not this exact product.

Must not be used by
  • Sugammadex Injection is contraindicated in patients with known hypersensitivity to sugammadex or any of its components.
  • Hypersensitivity reactions that occurred varied from isolated skin reactions to serious systemic reactions (i.e., anaphylaxis, anaphylactic shock) and have occurred in patients with no prior exposure to sugammadex [see Warnings and Precautions (5.1), Adverse Reactions (6)].
  • Known hypersensitivity to sugammadex or any of its components.
Most common side effects

Most common adverse reactions (reported in ≥10% of pediatric patients 2 to <17 years of age at Sugammadex Injection doses of 2 or 4 mg/kg) were pain, vomiting, and nausea.

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byMerck Sharp & Dohme B.V.
Active substanceSugammadex
Used inEverything that fits nowhere else, such as contrast media
Strength100 mg
Formsolución inyectable
ClassificationV03AB35 · Everything that fits nowhere else, such as contrast media
Routevía intravenosa
MarketedYes, according to the register
Name in the registerBRIDION 100 MG/ML SOLUCION INYECTABLE
Nº Registro08466001

Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician

Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.